Brokers Offer Predictions for Aurora Cannabis Q1 Earnings

Aurora Cannabis Inc. (NASDAQ:ACBFree Report) – Research analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk anticipates that the company will earn $0.17 per share for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.10) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2026 earnings at $0.02 EPS, Q3 2026 earnings at $0.40 EPS and Q4 2026 earnings at $0.29 EPS.

Several other research analysts also recently commented on ACB. TD Cowen began coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They set a “buy” rating for the company. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th.

Get Our Latest Report on ACB

Aurora Cannabis Price Performance

Shares of NASDAQ:ACB opened at $6.25 on Friday. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $342.86 million, a PE ratio of -8.22 and a beta of 1.84. The firm has a 50 day moving average of $4.24 and a 200-day moving average of $5.16. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35.

Aurora Cannabis (NASDAQ:ACBGet Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a negative return on equity of 2.19% and a negative net margin of 17.47%.

Institutional Investors Weigh In On Aurora Cannabis

A number of hedge funds have recently made changes to their positions in ACB. SBI Securities Co. Ltd. acquired a new position in Aurora Cannabis during the 4th quarter worth approximately $31,000. Cubist Systematic Strategies LLC bought a new stake in shares of Aurora Cannabis during the second quarter worth $50,000. Wealthspire Advisors LLC bought a new stake in Aurora Cannabis during the 4th quarter worth $149,000. Finally, Tidal Investments LLC increased its holdings in Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after purchasing an additional 34,988 shares in the last quarter. 47.63% of the stock is currently owned by institutional investors and hedge funds.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Featured Articles

Earnings History and Estimates for Aurora Cannabis (NASDAQ:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.